Fielmann is a high-quality, vertically integrated optical leader temporarily derated by German weakness, with 50.3% probability-weighted five-year upside if US integration and international growth execute.
Overview
Fielmann Group is a Germany-headquartered, vertically integrated omnichannel vision-care and audiology provider spanning frame design, lens glazing, D2C e-commerce, retail stores and clinical diagnostics. Prescription eyewear is the core revenue engine, while audiology, contact lenses and insurance services broaden customer value. **The company combines more than 50% German unit market share with approximately 80% gross margins**, supported by manufacturing control and Europe’s largest frame-and-lens purchasing scale. H1 2026 sales increased 1.8% to €1.25 billion and adjusted EBITDA rose 1.3% to €296.0 million, although the margin edged down to 23.7%. Spain grew 7.4% and US constant-currency growth was 3.3%, offsetting Germany’s 0.8% growth. Management cut FY2026 sales guidance to €2.50–€2.55 billion and adjusted EBITDA guidance to €560–€580 million because of German consumer caution. At €37.10, shares trade at 14.5x FY2026E P/E, 6.7x EV/EBITDA and offer an 11.0% FCF yield plus a 3.77% dividend yield. Near-term catalysts are US margin recovery, AI refraction, German normalization and continued international store expansion.